Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;58(1):41-45.
doi: 10.11622/smedj.2016044. Epub 2016 Feb 26.

Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions

Affiliations

Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions

Song Tao Timothy Cheo et al. Singapore Med J. 2017 Jan.

Abstract

Introduction: Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults. Although the survival rate for GBM has improved with recent advancements in treatment, the prognosis remains generally poor.

Methods: We conducted a retrospective review of GBM patients seen in National University Hospital, Singapore, and Tan Tock Seng Hospital, Singapore, from January 2002 to December 2011. Data on disease and treatment factors was collected and correlated with survival.

Results: Data on a total of 107 GBM patients was analysed. Their median survival time was 15.1 months and the two-year survival rate was 23.5%, which is comparable with data published in other series. The factors associated with improved median survival time were radiotherapy dose > 50 Gy (16.1 months vs. 8.7 months, p = 0.01) and adjuvant concurrent chemotherapy (16.4 months vs. 9.2 months, p = 0.003).

Conclusion: GBM confers a poor prognosis. Adjuvant radiotherapy and chemotherapy are associated with improved survival. Ethnicity may be a contributing factor to differences in GBM incidence and prognosis.

Keywords: brain tumour; clinical outcomes; glioblastoma multiforme.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Graph shows the overall survival of the patients, according to the radiotherapy dose they received.
Fig. 2
Fig. 2
Graph shows the overall survival of the patients, according to whether they underwent adjuvant concurrent chemotherapy treatment.

Comment in

References

    1. Darefsky AS, King JT, Jr, Dubrow R. Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries. Cancer. 2012;118:2163–72. - PMC - PubMed
    1. Jung KW, Yoo H, Kong HJ, et al. Population-based survival data for brain tumors in Korea. J Neurooncol. 2012;109:301–7. - PubMed
    1. Chen P, Aldape K, Wiencke JK, et al. Ethnicity delineates different genetic pathways in malignant glioma. Cancer Res. 2001;61:3949–54. - PubMed
    1. Das A, Tan WL, Teo J, Smith DR. Glioblastoma multiforme in an Asian population: evidence for a distinct genetic pathway. J Neurooncol. 2002;60:117–25. - PubMed
    1. Zainuddin N, Jaafar H, Isa MN, Abdullah JM. Malignant glioma: the involvement of loss of allelic heterozygosity and PTEN mutations in a group of Malay patients. Southeast Asian J Trop Med Public Health. 2005;36:748–56. - PubMed